Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer. It is specifically used for cancer that is HER2 receptor positive. It may be used by itself or together with other chemotherapy medication. Trastuzumab is given by slow injection into a vein and injection just under the skin.
Common side effects include fever, infection, cough, headache, trouble sleeping, and rash. Other severe side effects include heart failure, allergic reactions, and lung disease. Use during pregnancy may harm the baby. Trastuzumab works by binding to the HER2 receptor and slowing down cell replication.
Trastuzumab was approved for medical use in the United States in September 1998, and in the European Union in August 2000. It is on the World Health Organization's List of Essential Medicines.
Hospitali ya Taifa Muhimbili (MNH) imepokea taarifa zilizosambaa kwenye mitandao ya kijamii kuhusu madai ya kutokuwepo kwa dawa ya Trastuzumab, inayotumika katika matibabu ya baadhi ya wagonjwa wa saratani.
MNH inapenda kuufahamisha umma, wagonjwa na wadau wote kuwa dawa ya Trastuzumab...
Mama yangu anaumwa Saratani anafanya clinic yake pale Muhimbili kila baada ya wiki 3 anachoma sindano zinazoitwa IV TRASTUZUMAB 440mg kwa kila baada ya wiki 3, hiyo dawa ukiwa na bima unachangia Shilingi 618,000 kila ukienda kuchoma bila bima ni Shilingi 1,230,000.
Sasa yapata mwezi na wiki 3...
Anonymous
Thread
trastuzumabtrastuzumab 440mg
trastuzumab haipatikani
upungufu wa trustuzumab
JamiiForums uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.